Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated just now
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Hospital Antibiotic Pressure and Veterinary Antimicrobial Use: A One Health Analysis in Italy, 2022

Abstract

Background: Antimicrobial resistance (AMR) requires integrated One Health surveillance. In 2022, we coordinated the latest national hospital point prevalence survey (PPS3) in Italy. This study provides a national-level One Health overview of critically important antibiotic (CIA) classes for stewardship, in comparison to veterinary antimicrobial consumption data (ESVAC).

Methods: A descriptive ecological analysis was conducted using 2022 national aggregate data. We analyzed healthcare-associated infection (HAI) prevalence, antibiotic use, and resistance markers in acute care hospitals, alongside veterinary consumption (mg/PCU) of 3rd-4th generation cephalosporins, fluoroquinolones, and polymyxins.

Results: Among 60,404 patients included in PPS3, 41.7% received antibiotics. Ceftriaxone (16.1%) and penicillins with enzyme inhibitors were the most common agents. Enterobacterales resistance in HAIs reached 31.4% for 3rd-generation cephalosporins and 13.3% for carbapenems. In the veterinary sector, total sales in 2022 fell to 157.5 mg/PCU, a 46.6% reduction since 2016. CIA consumption remained low: 3rd-4th generation cephalosporins (0.08), fluoroquinolones (0.90), and polymyxins (0.58). The three most sold veterinary classes remain penicillins, tetracyclines, and sulfonamides.

Conclusions: Italy’s surveillance reveals an operational misalignment between sectors. Human data, supported by the national carbapenem-resistant Enterobacterals surveillance report for 2022 (showing 4.3 cases/100,000 inhabitants; 96.6% K. pneumoniae), emphasize high resistance burden in hospitals. While the veterinary sector successfully reduced CIA use, and EU zoonoses reports indicate stable trends, high resistance to common antimicrobials and increasing ciprofloxacin resistance in both human and animal isolates persist. These findings reinforce the necessity of a One Health approach to harmonize stewardship priorities across all sectors.

Key messages: • Italy shows a high burden of carbapenem-resistant infections in hospitals while veterinary efforts have reduced CIA use. Resistance to commonly used antibiotics remains a shared concern.

• The misalignment between human and veterinary sectors highlights the urgency of antimicrobial stewardship and an integrated One Health approach.

Related

  1. Knowledge and attitudes toward antimicrobial stewardship and the WHO AWaRe antibiotic classification among healthcare professionals at a tertiary hospital in Ethiopia
    Tamrat Assefa Tadesse, Sumeya Sani, Melaku Tileku Tamiru +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMicrobiologyCrossref
  2. Antimicrobial resistance and documented empirical antibiotic prescribing among cancer patients with culture-confirmed infections at a tertiary referral hospital in Rwanda, 2019-2024.
    Brandon Niyibizi Asuman, Damas Dukundane, Marrigje Jacoba Kreuger +4
    BMC infectious diseasesPeer-reviewedCC BYFull textMicrobiologyEurope PMCDOAJ
  3. Antibiotic prescribing patterns, antimicrobial stewardship implementation barriers and readiness at primary health care centres in eastern Uttar Pradesh, India
    Neha Srivastava, Ashok Kumar Pandey, Laiba Jamal Ahmad +6
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textMicrobiologyCrossrefPMC
  4. Antimicrobial practices for Mycoplasma infections in cattle: A survey of veterinary practitioners in light of current scientific evidence and national guidelines
    Susan Saudoyez, Anneke Feberwee, Jade Bokma +11
    Veterinary JournalPeer-reviewedCC BY 4.0Full textMicrobiologyHAL
  5. Knowledge and attitudes toward antimicrobial use, resistance, and stewardship among final-year veterinary students: a multinational cross-sectional survey.
    Mahmoud Eltholth, Jadesola Juliana Ajao, Shrikrishna Isloor +19
    Frontiers in veterinary sciencePeer-reviewedCC BYFull textMicrobiologyEurope PMC
BibTeX
@article{ruggeri2026hospital,
  title = {{Hospital Antibiotic Pressure and Veterinary Antimicrobial Use: A One Health Analysis in Italy, 2022}},
  author = {S Ruggeri and V Imbriano and L Bresciano and S Bazzolo and M Castagnotto and V Nunziata and CM Zotti and C Vicentini},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.812},
  url = {https://doi.org/10.1093/eurpub/ckag169.812},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Hospital Antibiotic Pressure and Veterinary Antimicrobial Use: A One Health Analysis in Italy, 2022
AU  - S Ruggeri
AU  - V Imbriano
AU  - L Bresciano
AU  - S Bazzolo
AU  - M Castagnotto
AU  - V Nunziata
AU  - CM Zotti
AU  - C Vicentini
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.812
UR  - https://doi.org/10.1093/eurpub/ckag169.812
AB  - Background: Antimicrobial resistance (AMR) requires integrated One Health surveillance. In 2022, we coordinated the latest national hospital point prevalence survey (PPS3) in Italy. This study provides a national-level One Health overview of critically important antibiotic (CIA) classes for stewardship, in comparison to veterinary antimicrobial consumption data (ESVAC).  Methods: A descriptive ecological analysis was conducted using 2022 national aggregate data. We analyzed healthcare-associated infection (HAI) prevalence, antibiotic use, and resistance markers in acute care hospitals, alongside veterinary consumption (mg/PCU) of 3rd-4th generation cephalosporins, fluoroquinolones, and polymyxins.  Results: Among 60,404 patients included in PPS3, 41.7% received antibiotics. Ceftriaxone (16.1%) and penicillins with enzyme inhibitors were the most common agents. Enterobacterales resistance in HAIs reached 31.4% for 3rd-generation cephalosporins and 13.3% for carbapenems. In the veterinary sector, total sales in 2022 fell to 157.5 mg/PCU, a 46.6% reduction since 2016. CIA consumption remained low: 3rd-4th generation cephalosporins (0.08), fluoroquinolones (0.90), and polymyxins (0.58). The three most sold veterinary classes remain penicillins, tetracyclines, and sulfonamides.  Conclusions: Italy’s surveillance reveals an operational misalignment between sectors. Human data, supported by the national carbapenem-resistant Enterobacterals surveillance report for 2022 (showing 4.3 cases/100,000 inhabitants; 96.6% K. pneumoniae), emphasize high resistance burden in hospitals. While the veterinary sector successfully reduced CIA use, and EU zoonoses reports indicate stable trends, high resistance to common antimicrobials and increasing ciprofloxacin resistance in both human and animal isolates persist. These findings reinforce the necessity of a One Health approach to harmonize stewardship priorities across all sectors.  Key messages: • Italy shows a high burden of carbapenem-resistant infections in hospitals while veterinary efforts have reduced CIA use. Resistance to commonly used antibiotics remains a shared concern.  • The misalignment between human and veterinary sectors highlights the urgency of antimicrobial stewardship and an integrated One Health approach.
SN  - 1101-1262
SN  - 1464-360X
ER  -